4.5 Review

The role of modulatory calcineurin-interacting proteins in calcineurin signaling

期刊

TRENDS IN CARDIOVASCULAR MEDICINE
卷 13, 期 1, 页码 15-21

出版社

ELSEVIER SCIENCE LONDON
DOI: 10.1016/S1050-1738(02)00188-3

关键词

-

资金

  1. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072016] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR040849, R01AR040849] Funding Source: NIH RePORTER
  3. NHLBI NIH HHS [R01 HL072016] Funding Source: Medline
  4. NIAMS NIH HHS [AR40849] Funding Source: Medline

向作者/读者索取更多资源

Modulatory calcineurin-interacting proteins (MCIPs), also known as the Down syndrome critical region 1 (DSCR1) and DSCR1-like proteins, are a recently described family of small, structurally related proteins that are preferentially expressed in heart, skeletal muscle, and brain. MCIP proteins can bind to and inhibit calcineurin, a calcium/calmodulin-regulated serine/threonine protein phosphatase that is activated during cardiac hypertrophy and failure. Transcription of the mammalian MCIP1 gene is induced by calcineurin, suggesting that it functions as an endogenous feedback regulator of calcineurin signal transduction. Forced expression of human MCIP1 protein in the hearts of transgenic mice attenuates the hypertrophic response to a broad range of stimuli. This review summarizes work from a number of laboratories on the structure, regulation, and function of MCIP proteins. (C) 2003 Elsevier Science Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据